Affiliated to research
I am a specialist in Haematology at the Karolinska University Hospital. I finished my PhD-studies at the Department of Oncology, Lund University, in 2016 and have worked with lymphoma research since 2010. In September 2017 I joined the Cancer Epidemiology group at KEP as a post-doc.
My research focus is on malignant lymphomas, with a special interest in aggressive subtypes such as diffuse large B-cell lymphoma, Burkitt lymphoma and primary mediastinal B-cell lymphoma. By using real-world data from national lymphoma registers linked to other databases I investigate the impact of prognostic factors, treatment and outcomes among patients with lymphoma in a population-based setting. I have several ongoing collaborative projects within the Nordic lymphoma group, to increase power to enable study of rare lymphoma subtypes.
I also have an interest in precision medicine and tumour biology and am one of the main organisers of the clinic prospective study BioLymph. Biolymph is a collaborative project between the department of haematology, pathology and clinical genetics that prospectively collects tumour- and blood samples for all patients with newly diagnosed lymphomas at the Karolinska University hospital. NGS sequencing is performed on tumour material and longitudinally on circulating tumour DNA. The aim of this research is to increase knowledge of the impact of genetic aberrations on prognosis and response to treatment to facilitate implementation of precision medicine in lymphoma care. The ultimate goal is to improve survival for patients with lymphoma through more tailored and tolerable treatment. Currently, more than 320 patients are enrolled with inclusion ongoing. I also participate as a co-investigator in several ongoing clinical trials at the department of Haematology.
Main supervisor to doctoral student Johanna Borg Bruchfeld with the project title "Sex-related differences in incidence and outcomes among patients with lymphoma: epidemiological and biological perspectives"
Co-supervisor to doctoral student Joel Joelsson with the project title "Second malignancies after non-Hodgkin lymphoma diagnosis and early identification of patients with poor outcomes"
Co-supervisor to doctoral student Linn Deleskog Spångberg with the project title "Long-term outcome and prognostic factors in follicular lymphoma and Hodgkin lymphoma - population-based studies using registers and new precision medicine biomarkers"
Organiser of Epidemiology Courses during Block II & IV in NatiOn: National Research School in Clinical and Translational Cancer Research
Organiser of the annual Young Researchers in Hematology Conference at Karolinska Institutet
Mentor at the course in professional development for medical student at Karolinska institutet since 2017
MD, Lund University, 2014
PhD, Lund University, 2016, Thesis title: Burkitt lymphoma and diffuse large B-cell lymphoma – therapeutic strategies and pathogenetic mechanisms
Post-doc, Karolinska Institutet, since 2017